Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00683540 · ClinicalTrials.gov registry record

Formative Evaluation in Implementation Research: Guideline Development

A clinical trial of Chronic Disease, sponsored by VA Office of Research and Development.

Completed
Registry status
9
Enrollment target
1
Study location

NCT00683540: Completed study of Chronic Disease, sponsored by VA Office of Research and Development.

NCT00683540 is a study of Chronic Disease that has completed, run by VA Office of Research and Development. The registered enrollment target is 9 participants, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00683540, a study of Chronic Disease, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
9 participants
Enrollment target
1
Study location

Study Summary

The Veterans Administration (VA) has embraced the use of implementation research as a critical way to improve care by facilitating the adoption of proven medical practices. Yet implementation science still remains rudimentary. Challenges exist in judging the success of an implementation project. Rather than relying solely on hard outcomes, an investigator must also assess how effectively an intervention is put into place at a site. This assessment comes via a formative evaluation (FE) plan. The FE plan can contain such diverse data elements as the number of fliers distributed about the intervention, how often an intervention advocate speaks to participants, the content derived from team meeting notes, and themes extracted from focus groups. The diversity of such data elements can appear foreign to investigators trained in traditional health services research. The FE plan can also lead to confusion about what to measure, when, and how to integrate the various measures into a unified whole. Complicating matters is the fact that FE is often qualitative--such as interviews, focus groups, and meeting notes which can make data difficult for investigators to interpret. Thus, there is a pressing need to provide clarity on how FE is to be used in implementation studies. This Short Term Project proposal offers a three-part approach toward specifying the best FE practices: first, a systematic review of the literature; second, qualitative interviews with VA implementation investigators; and third, a panel discussion of national experts, funded through a VA Implementation Collaborative Award. The panel discussion will outline FE guidelines based on the researchers expertise, the systematic review, and the qualitative interviews.

Conditions Studied

Study Locations (1)

Pennsylvania

  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2009-01-23
Est. Completion 2009-03-31
VA Office of Research and Development

1,668 total trials

What the finished NCT00683540 record still lists

NCT00683540 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 89,943-participant average among 48 other Chronic Disease trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Chronic Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00683540 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00683540 about?

NCT00683540 is a clinical study titled "Formative Evaluation in Implementation Research: Guideline Development". The Veterans Administration (VA) has embraced the use of implementation research as a critical way to improve care by facilitating the adoption of proven medical practices. Yet implementation science still remains rudimentary. Challenges exist in judging the success of an implementation project. Rat...

What is the current status of trial NCT00683540?

This trial is currently completed. The enrollment target is 9 participants. The study started on 2009-01-23. Estimated completion is 2009-03-31.

What conditions does trial NCT00683540 study?

This clinical trial studies the following conditions: Chronic Disease.

Who is sponsoring clinical trial NCT00683540?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00683540 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00683540's enrollment target sits among peer trials

9 48th of 48 higher than 1 of 48 other Chronic Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00683540, the US trial registry maintained by the National Library of Medicine. NCT00683540 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.